報告_MS_力積電6770_20260519

PDF 原檔:報告_MS_力積電6770_20260519_original.pdf

原始內容

M May 18, 2026 11:48 PM GMT

Powerchip Semiconductor Manufacturing Co | Asia Pacific

Beneficiary of mature node upcycle and EMIB supply chain

What’s Changed Powerchip SemiconductorFromTo
Price TargetNT$71.00NT$88.00

We raise our price target from NT88. EPS estimates are down 46% for 2026 but up 71% for 2027. PSMC is set to benefit from a mature node shortage in 2H27, AP Memory’s emerging revenue streams from the EMIB supply chain, and continued price hikes and utilization rate improvements.

Mature node up-cycle begins : In The Foundry Floorplan: All boats riding on the same tide - mature node up-cycle begins, we highlighted that we expect a mature node capacity shortage in 2H27, arising from fast growth of AI power ICs as a key part of future AI infrastructure. AI power ICs should more than offset weak consumer and smartphone semi demand. AI infrastructure build-outs are likely to last another two years, so some smartphone and PC customers are now worrying about future mature node shortages. We have therefore raised our ratings and/or valuations of multiple mature node foundries.

A beneficiary as AP Memory’s foundry partner in S-SiCap production: We estimate that this will make up 3% of PSMC’s total revenue in 2026, 5% in 2027, and 9% in 2028. In Old Memory - Reaffirming Asymmetric Risks, we discussed how AP Memory’s S-SiCap business may benefit from: 1) penetration of the EMIB supply chain by supplying IPDs (integrated passive devices) to Humufish TPUs in 2027/28; 2) high growth of AI GPU shipments for China. See Exhibit 1 .

Memory price hikes continue: For the traditional memory foundry business, PSMC continues to engage in monthly price negotiations with customers; we expect memory foundry price hikes to continue. See also Shawn Kim’s report, Agentic AI The Surge Begins: we have expanded our memory TAM forecast to reflect agentic AI demand, reflecting our continued bullish view on the broader memory market.

EPS estimates down 46% for 2026 but up 71% for 2027: We introduce our 2028 forecasts. See PSMC: Earnings Estimate Revisions .

Raise price target from NT88; remain OW: We now apply a target 2026e P/B of 2.1x, on BVPS of NT50.9 BVPS). We estimate the revenue mix in 2027 between memory, analog, ad logic to be ~48%/30%/22%. If we attribute 52% of the 2027e BVPS to the analog and logic businesses and assume a 3.2x P/B ratio for them (vs. 2027e P/B of 3.3x for UMC and 3.7x for VIS), it would contribute NT$85 of our price target, - implying an almost free valuation for the memory business.

Idea

Morgan Stanley Taiwan Limited+ Daniel Yen, CFA Equity Analyst Daniel.Yen@morganstanley.com+886 2 2730-2863
Charlie Chan Equity Analyst Charlie.Chan@morganstanley.com Morgan Stanley Asia Limited++886 2 2730-1725
Daisy Dai, CFA Equity Analyst Daisy.Dai@morganstanley.com+852 2848-7310
Tiffany Yeh Equity Analyst Tiffany.Yeh@morganstanley.com+886 2 7712-3032
Ethan Jia Research Associate Ethan.Jia@morganstanley.com+852 3963-2287

Powerchip Semiconductor Manufacturing Co (6770.TW, 6770 TT)

Greater China Technology Semiconductors | Taiwan

Stock RatingOverweightOverweight
Industry ViewAttractive
Price targetNT$88.00
Up/downside to price target(%)40
Shr price, close (May 15,2026)NT$62.80
52-Week RangeNT$78.90-14.50
Sh out, dil, curr (mn)4,188
Mkt cap, curr (mn)NT$263,001
EV, curr (mn)
NT$250,225NT$250,225
Avg daily trading value(mn)NT$5,961NT$5,961
Fiscal Year Ending12/2512/26e12/27e12/28e
EPS (NT$)**(1.87)4.643.784.43
Prior EPS (NT$)**(1.64)8.612.21-
EPS (NT$)§(1.89)5.943.86-
Revenue, net (NT$ mn)46,73073,01489,83591,960
EBITDA (NT$ mn)(309)13,00927,57329,481
ModelWare net inc (NT(11,444)4,36416,39519,420
$ mn)
P/ENM64.017.815.1
P/BV2.01.51.21.0
RNOA (%)(8.7)5.939.853.3
ROE (%)(12.9)5.38.48.2
EV/EBITDANM10.03.11.3
Div yld (%)0.0---
FCF yld ratio (%)**4.736.417.117.6
Leverage (EOP) (%)(15.6)(80.7)(85.8)(89.0)

Morgan Stanley does and seeks to do business with companies covered in Morgan Stanley Research. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of Morgan Stanley Research. Investors should consider Morgan Stanley Research as only a single factor in making their investment decision.